Robert Spranger

590 total citations
24 papers, 446 citations indexed

About

Robert Spranger is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Urology. According to data from OpenAlex, Robert Spranger has authored 24 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 7 papers in Urology. Recurrent topics in Robert Spranger's work include Prostate Cancer Diagnosis and Treatment (11 papers), Urinary Bladder and Prostate Research (6 papers) and Prostate Cancer Treatment and Research (6 papers). Robert Spranger is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (11 papers), Urinary Bladder and Prostate Research (6 papers) and Prostate Cancer Treatment and Research (6 papers). Robert Spranger collaborates with scholars based in Austria, Germany and Japan. Robert Spranger's co-authors include Wolfgang Horninger, Andreas P. Berger, Hannes Steiner, Jasmin Bektić, Georg Bartsch, Elisabeth Niemoeller, Ferdinand Frauscher, Alexandré Pelzer, Michael Kühn and Georg Bartsch and has published in prestigious journals such as PLoS ONE, Diabetes Care and The Journal of Urology.

In The Last Decade

Robert Spranger

24 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Spranger Austria 13 214 119 119 118 89 24 446
Wagner Eduardo Matheus Brazil 13 214 1.0× 134 1.1× 83 0.7× 48 0.4× 35 0.4× 41 361
Oded Kessler Israel 15 165 0.8× 312 2.6× 186 1.6× 30 0.3× 163 1.8× 28 651
Mark Preston United States 11 430 2.0× 164 1.4× 60 0.5× 22 0.2× 123 1.4× 28 684
Ioannis Zachos Greece 11 137 0.6× 153 1.3× 30 0.3× 18 0.2× 55 0.6× 43 302
Krzysztof Tupikowski Poland 12 76 0.4× 80 0.7× 39 0.3× 22 0.2× 42 0.5× 34 270
Shengfu Chen China 8 37 0.2× 43 0.4× 46 0.4× 38 0.3× 52 0.6× 12 300
Paul T. Gellhaus United States 12 209 1.0× 175 1.5× 80 0.7× 12 0.1× 94 1.1× 26 359
Jörgen U. Schlegel United States 9 206 1.0× 111 0.9× 32 0.3× 39 0.3× 37 0.4× 22 400
Zeina Chakhtoura France 11 21 0.1× 44 0.4× 43 0.4× 271 2.3× 288 3.2× 27 542
Alejandro Livoff Israel 10 48 0.2× 52 0.4× 16 0.1× 24 0.2× 63 0.7× 29 266

Countries citing papers authored by Robert Spranger

Since Specialization
Citations

This map shows the geographic impact of Robert Spranger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Spranger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Spranger more than expected).

Fields of papers citing papers by Robert Spranger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Spranger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Spranger. The network helps show where Robert Spranger may publish in the future.

Co-authorship network of co-authors of Robert Spranger

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Spranger. A scholar is included among the top collaborators of Robert Spranger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Spranger. Robert Spranger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barrientos‐Pérez, Margarita, Daniel S. Hsia, Lance Alan Sloan, et al.. (2022). A study on pharmacokinetics, pharmacodynamics and safety of lixisenatide in children and adolescents with type 2 diabetes. Pediatric Diabetes. 23(6). 641–648. 10 indexed citations
4.
Hahn, Friedrich, Robert Spranger, Pia Rauch, et al.. (2017). Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent manner. PLoS ONE. 12(4). e0174254–e0174254. 8 indexed citations
5.
Funk, Markus B., et al.. (2015). Überwachung der Sicherheit von Zelltherapeutika (CBMPs). Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 58(11-12). 1239–1246. 1 indexed citations
6.
Haasbach, Emanuel, et al.. (2011). Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses. Antiviral Research. 91(3). 304–313. 24 indexed citations
7.
Spranger, Robert, Andrea Hartner, Ralf L. Schild, et al.. (2008). Leptin Expression in Primary Trophoblast Cells in Response to Incubation with the Serum of Preeclamptic Women. Hypertension in Pregnancy. 27(3). 267–277. 5 indexed citations
8.
Berger, Andreas P., Martina Deibl, Alexander Strasak, et al.. (2006). Relapse after radical prostatectomy correlates with preoperative PSA velocity and tumor volume: Results from a screening population. Urology. 68(5). 1067–1071. 19 indexed citations
9.
Berger, Andreas P., Wolfgang Horninger, Jasmin Bektić, et al.. (2006). Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease?. British Journal of Urology. 98(3). 587–590. 46 indexed citations
10.
Berger, Andreas P., Martina Deibl, Hannes Steiner, et al.. (2005). Longitudinal PSA changes in men with and without prostate cancer: Assessment of prostate cancer risk. The Prostate. 64(3). 240–245. 43 indexed citations
11.
Meißner, Udo, et al.. (2005). Hypoxia-induced leptin production in human trophoblasts does not protect from apoptosis. European Journal of Endocrinology. 153(3). 455–461. 28 indexed citations
12.
Berger, Andreas P., Ferdinand Frauscher, Ethan J. Halpern, et al.. (2003). Periprostatic administration of local anesthesia during transrectal ultrasound-guided biopsy of the prostate: a randomized, double-blind, placebo-controlled study. Urology. 61(3). 585–588. 56 indexed citations
13.
Steiner, Hannes, Patrizia Moser, Martina Hager, et al.. (2003). Clinical and pathologic features of prostate cancer detected after repeat false‐negative biopsy in a screening population. The Prostate. 58(3). 277–282. 14 indexed citations
14.
Berger, Andreas P., Robert Spranger, Kurt Kofler, et al.. (2003). Early detection of prostate cancer with low PSA cut‐off values leads to significant stage migration in radical prostatectomy specimens. The Prostate. 57(2). 93–98. 23 indexed citations
16.
Berger, André, Robert Spranger, Hannes Steiner, Georg Bartsch, & Wolfgang Horninger. (2003). Early detection with low PSA cut-off values leads to significant stage migration in radical prostatectomy specimens. European Urology Supplements. 2(1). 129–129. 4 indexed citations
17.
Pinggera, Germar‐Michael, et al.. (2003). Congenital Absence of the Right Renal vein. The Journal of Urology. 170(3). 914–915. 4 indexed citations
18.
Spranger, Robert, et al.. (2002). Intravesical Free-floating Prostate. The Journal of Urology. 2543–2544. 1 indexed citations
19.
Spranger, Robert, et al.. (2002). Polyorchidism: A Strange Anomaly With Unsuspected Properties. The Journal of Urology. 168(1). 198–198. 38 indexed citations
20.
Spranger, Robert, et al.. (2002). Polyorchidism: A Strange Anomaly With Unsuspected Properties. The Journal of Urology. 198–198. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026